For example, in the analyses by tumor sites, the ERCC4 rs2276466 and rs3136038 were only found to be associated with risk of oropharyngeal cancer but not for cancers of oral cavity, hypopharynx and larynx. Here, ERCC4 is linked to oral cavity cancer.